The invention relates to a calcium channel blocker selected from the group of the calcium channel blockers of the phenylalkylamine family, the calcium channel blockers of the amino acid family, and the calcium channel blockers of the benzofuran family, for the use thereof in the treatment of a motor neuronopathy.